These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22536580)

  • 1. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.
    Marciniuk DD; Hernandez P; Balter M; Bourbeau J; Chapman KR; Ford GT; Lauzon JL; Maltais F; O'Donnell DE; Goodridge D; Strange C; Cave AJ; Curren K; Muthuri S;
    Can Respir J; 2012; 19(2):109-16. PubMed ID: 22536580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of augmentation therapy in alpha-1 antitrypsin deficiency.
    Kueppers F
    Curr Med Res Opin; 2011 Mar; 27(3):579-88. PubMed ID: 21226542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Well-Known and Less Well-Known Functions of Alpha-1 Antitrypsin. Its Role in Chronic Obstructive Pulmonary Disease and Other Disease Developments.
    Janciauskiene S; Welte T
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S280-8. PubMed ID: 27564662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
    Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
    Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fibrinogen cleavage product Aα-Val360, a specific marker of neutrophil elastase activity in vivo.
    Carter RI; Mumford RA; Treonze KM; Finke PE; Davies P; Si Q; Humes JL; Dirksen A; Piitulainen E; Ahmad A; Stockley RA
    Thorax; 2011 Aug; 66(8):686-91. PubMed ID: 21617168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
    Hubbard RC; Crystal RG
    Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized Alpha-1-Antitrypsin as a Potential Biomarker Associated with Onset and Severity of Chronic Obstructive Pulmonary Disease in Adult Population.
    Topic A; Milovanovic V; Lazic Z; Ivosevic A; Radojkovic D
    COPD; 2018 Oct; 15(5):472-478. PubMed ID: 30822244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lack of effect of substitution therapy of alpha1-antitrypsin deficiency].
    Dahl R; Hilberg O; Løkke A; Pedersen L; Ringbæk T; Titlestad I
    Ugeskr Laeger; 2011 Oct; 173(42):2645-7. PubMed ID: 22027165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
    Parr DG; Lara B
    Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation therapy with alpha1-antitrypsin: patterns of use and adverse events.
    Stoller JK; Fallat R; Schluchter MD; O'Brien RG; Connor JT; Gross N; O'Neil K; Sandhaus R; Crystal RG
    Chest; 2003 May; 123(5):1425-34. PubMed ID: 12740257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha 1-antitrypsin-deficiency-related emphysema.
    Barker AF
    J Am Board Fam Pract; 1992; 5(5):489-93. PubMed ID: 1414450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1 Antitrypsin Augmentation Therapy Improves Survival in Severely Deficient Patients with Predicted FEV1 Between 10% and 60%: A Retrospective Analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry.
    Rahaghi FF; Monk R; Ramakrishnan V; Beiko T; Strange C
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3193-3199. PubMed ID: 33299307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.
    Campos MA; Lascano J
    Ther Adv Respir Dis; 2014 Oct; 8(5):150-61. PubMed ID: 25013223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency.
    Petrache I; Hajjar J; Campos M
    Biologics; 2009; 3():193-204. PubMed ID: 19707408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha1-antitrypsin deficiency: a position statement of the Canadian Thoracic Society.
    Abboud RT; Ford GT; Chapman KR;
    Can Respir J; 2001; 8(2):81-8. PubMed ID: 11320399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial.
    Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG;
    Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
    Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
    Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.